MADD
MADD (MAP kinase activating death domain, also known as DENN, RAB3GEP, IG20 and KIAA0358) is a guanyl-nucleotide exchange factor for Rab GTPases and a death domain-containing adaptor protein. It links TNF receptor signalling to MAP kinase activation and supports vesicle trafficking in neurons. Browse Assay Genie's current range of MADD research reagents below, or read on for the biology behind the target.
MADD acts as a guanyl-nucleotide exchange factor that regulates small GTPases of the Rab family. It converts the GDP-bound inactive forms of RAB27A and RAB27B to their GTP-bound active forms, and does the same for RAB3A, RAB3C and RAB3D, GTPases involved in synaptic vesicle exocytosis and vesicle secretion. The protein plays a role in synaptic vesicle formation and in vesicle trafficking at the neuromuscular junction, and it is involved in up-regulating a post-docking step of synaptic exocytosis in central synapses. Probably through binding to the motor proteins KIF1B and KIF1A, it mediates motor-dependent transport of GTP-RAB3A-positive vesicles to presynaptic nerve terminals.
The MADD gene encodes a death domain-containing adaptor protein that is membrane-bound, with additional cytoplasmic and axonal localisation reported. It interacts with the death domain of TNF-alpha receptor 1 (TNFRSF1A) and may link this receptor with MAP kinase activation. MADD plays a role in TNF-alpha-mediated activation of the MAPK pathway, including ERK1/2, and may be involved in regulating TNF-alpha-induced apoptosis. According to the NCBI Gene summary, it is expressed at a higher level in neoplastic cells than in normal cells, and several transcript variants encoding different isoforms have been described.
MADD belongs to the MADD family and sits within the HGNC group of DENN domain containing proteins. The name DENN is one of several aliases, alongside RAB3GEP, IG20 and KIAA0358, and the earlier HGNC name was MAP-kinase activating death domain. Orthologous Madd genes are annotated in mouse and rat, which supports the use of rodent models in studies of MADD biology.
MADD activates RAB3 proteins and supports synaptic vesicle formation and exocytosis, making it relevant to studies of neurotransmitter release.
As an exchange factor for RAB27A, RAB27B and RAB3 isoforms, MADD is used to examine how GDP-GTP cycling controls vesicle secretion.
MADD interacts with TNFRSF1A and contributes to TNF-alpha-driven MAPK and ERK1/2 activation, a focus for death receptor pathway research.
MADD may regulate TNF-alpha-induced apoptosis and is expressed at higher levels in neoplastic cells, prompting interest in tumour cell survival.
MADD is a guanyl-nucleotide exchange factor that activates Rab GTPases, including RAB27A, RAB27B and RAB3A, C and D, by promoting GTP binding. It supports synaptic vesicle trafficking and exocytosis, and it also helps transmit TNF-alpha signals to the MAPK pathway.
The protein has been named after different functions and discovery routes: DENN for its domain, RAB3GEP for its Rab3 exchange activity, IG20 and KIAA0358 as gene identifiers. HGNC uses MAP kinase activating death domain. NCBI also describes several transcript variants encoding different isoforms.
Mouse and rat both carry an orthologous Madd gene. The NCBI Gene summary notes that MADD is expressed at a higher level in neoplastic cells than in normal cells, and it may be involved in TNF-alpha-induced apoptosis. Check the datasheet of any product for its validated reactivity.
Rab GTPases, kinesin motors, TNF receptor signalling components and MAPK pathway proteins related to MADD biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8WXG6; product specifications from Assay Genie datasheets.